JPM-OEt,262381-84-0

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

JPM-OEt

CAS No. : 262381-84-0

MCE 国际站：JPM-OEt

产品活性：JPM-OEt 是一种广谱的半胱氨酸组织蛋白酶 (cysteine cathepsin) 抑制剂。JPM-OEt 在活性位点共价结合，并且不可逆地抑制半胱氨酸组织蛋白酶家族。具有抗肿瘤活性。

研究领域：Metabolic Enzyme/Protease

作用靶点：Cathepsin

In Vivo: JPM-OEt (50 mg/kg; i.p.; daily for 30 days) reduces tumor cathepsin B activity significantly.
JPM-OEt (50 mg/kg; i.p.; twice daily for 4 weeks) leads to tumor regression in the RIP1-Tag2 (RT2) mouse model of pancreatic islet cell tumorigenesis.
JPM-OEt (50 mg/kg; i.p.; daily from 63 to 98 days) causes a significant delay in the increase of tumour burden during the first 2 weeks of treatment.

相关产品：Covalent Screening Library Plus  |  Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Anti-Cancer Compound Library  |  Covalent Screening Library  |  Angiogenesis-Related Compound Library  |  Targeted Diversity Library  |  Heterocyclic Compound Library  |  Membrane Protein-targeted Compound Library  |  Cysteine Targeted Covalent Library  |  Leupeptin hemisulfate  |  N-Ethylmaleimide  |  Aloxistatin  |  PMSF  |  E-64  |  CA-074 methyl ester  |  Papain  |  Calpeptin  |  CA-074  |  p-Aminophenylmercuric acetate  |  Z-FY-CHO  |  LY 3000328  |  Odanacatib  |  SID 26681509  |  Z-FA-FMK  |  K777  |  Balicatib  |  Cathepsin inhibitor 1  |  L-006235  |  Petesicatib  |  Z-LVG-CHN2  |  GSK-2793660  |  LHVS  |  Chymostatin  |  Z-WEHD-FMK  |  Cathepsin X-IN-1  |  S130  |  3-Epiursolic Acid  |  KGP94  |  VBY-825

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds